MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202511000621 A) filed by Zoencure Therapeutics Private Limited on January 03, 2025, for Humanized Anti-Cd19 Chimeric Antigen Receptor (car) For Treatment Of Diseases Associated With Cd19 Expression, Composition And Preparation Thereof.
Inventors include Deepak Rohila; and Rahul Katara.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT The present invention relates to humanized anti-CD19 chimeric antigen receptor (CAR) polypeptide for the treatment of diseases associated with CD19 expression, such as B-cell malignancies. The present invention further relates to its nucleic acid encoding the CAR...